Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-05

Clinical Trial Update: A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for dexpramipexole in adolescents and adults with eosinophilic asthma; the study is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexpramipexole (dexpramipexole)

Snippet

Sponsor: Areteia Therapeutics | Conditions: Eosinophilic Asthma, Asthma; Eosinophilic | Phase 3 | Status: ACTIVE_NOT_RECRUITING